Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients

Annals of Clinical Biochemistry

Volumn 41, Issue 6, 2004, Pages 469-473

  Burbea, Zvi ^a   Nakhoul, Farid ^a,b   Zoabi, Roaa ^b   Hochberg, Irit ^b   Levy, Nina S ^b   Benchetrit, Sidney ^c,d   Weissgarten, Joshua ^d,e   Tovbin, David ^f   Knecht, Aaron ^c,g   Iaina, Adrian ^c,h   Herman, Michal ^c,i   Kristal, Batya ^b   Levy, Andrew P ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Sapir Medical Center   (Israel)

^e ASSAF HAROFEH MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g SHEBA MEDICAL CENTER   (Israel)

^h TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

ⁱ RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN;

ADULT; AGED; ALGORITHM; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; EVALUATION; FEMALE; HAPTOGLOBIN PHENOTYPE; HEMODIALYSIS; HUMAN; ISRAEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS;

AGED; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPTOGLOBINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

BACTERIA (MICROORGANISMS);

EID: 9644287918     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563042466758     Document Type: Article

References (15)

1. Bowman BH, Kurosky A. Haptoglobin: The evolutionary product of duplication, unequal crossing over and point mutation. Adv Hum Genet 1982; 12: 189-261
2. Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B. Effects of haptoglobin phenotypes on growth of streptococcus pyogenes. Clin Chem Lab Med 1998; 36: 691-6
3. Levy AP, Hochberg I, Jablonski K, Resnick HE, Best L, Lee E, et al. Haptoglobin phenotype and the risk of cardiovascular disease in individuals with diabetes. J Am Coll Cardiol 2002; 40: 1984-90
4. Awadallah S, Hamad M. A study of haptoglobin phenotype in patients with chronic renal failure. Ann Clin Biochem 2003; 40: 680-3
5. Burbea Z, Nakhoul F, Rosenberg S, Zoabi R, Skorecki K, et al. The role of haptoglobin phenotype in end stage kidney disease. Exp Nephrol 2004; 97: e71-6
6. Walters G, Warwick G, Walls J. Analysis of patients dying within one year of starting renal replacement therapy. Am J Nephrol 2000; 20: 358-63
7. US Renal Data System. USRDS 2002 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
8. Hamad M, Awadallah S. Age group-associated variations in the pattern of Hp type distribution in Jordanians. Clin Chim Acta 2003; 300: 75-81
9. Hochberg I, Roguin A, Nikolsky E, Chanderaskekhar PV, Cohen S, Levy AP. Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 2002; 161: 441-6
10. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schomig A, et al. Genotyping of common haptoglobin polymorphism Hp based on the polymerase chain reaction. Clin Chem 2002; 48: 1377-82
11. Samak MJ, Jaber BL. Mortality caused by sepsis in patients with end stage renal disease compared with the general population. Kid Int 2000; 58: 1758-64
12. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, DeBuyzere ML, et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000; 46: 1619-25
13. Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clin Chem Lab Med 2002; 40: 212-6
14. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the hemoglobin scavenger receptor. Nature 2001; 409: 198-201
15. Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbowicz F, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res 2003; 92: 1193-200